EIF4EBP1 and renal cell carcinoma: Notwithstanding these limitations, results from the current study underscore that p-4EBP1 may serve as a hallmark or funnel factor where upstream oncogenic signals converge and dephosphorylation of 4E-BP1 could be a powerful therapeutic options in Xp11.2 RCC.